Detalhe da pesquisa
1.
Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial.
Circulation
; 146(9): 687-698, 2022 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35946404
2.
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
N Engl J Med
; 382(13): 1208-1218, 2020 03 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32050061
3.
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
Eur Heart J
; 43(13): 1307-1316, 2022 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34617993
4.
Low Transvalvular Flow Rate in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) Is a Predictor of Mortality: The TFR-TAVI Study.
Heart Lung Circ
; 32(12): 1489-1499, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37993343
5.
Coronary revascularization in patients with left ventricle systolic dysfunction, current challenges and clinical outcomes.
Rev Cardiovasc Med
; 23(1): 33, 2022 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35092225
6.
Mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock.
Rev Cardiovasc Med
; 23(2): 71, 2022 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35229562
7.
Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients.
Catheter Cardiovasc Interv
; 99(1): 74-84, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33942465
8.
Safety and efficacy of Everolimus-Eluting bioabsorbable Polymer-Coated stent in patients with long coronary lesions: The EVOLVE 48 study.
Catheter Cardiovasc Interv
; 99(2): 373-380, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34051049
9.
Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.
Catheter Cardiovasc Interv
; 99(3): 533-540, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34463427
10.
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
Catheter Cardiovasc Interv
; 99(3): 583-592, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34478233
11.
Aspirin Versus Dual Antiplatelet Therapy in Patients Undergoing Trans-Catheter Aortic Valve Implantation, Updated Meta-Analysis.
Cardiovasc Drugs Ther
; 36(2): 279-283, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33587229
12.
Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England.
J Intern Med
; 290(1): 88-100, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33462815
13.
Survival relative to pacemaker status after transcatheter aortic valve implantation.
Catheter Cardiovasc Interv
; 98(3): E444-E452, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33502784
14.
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.
Lancet
; 393(10175): 987-997, 2019 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30827782
15.
Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
Catheter Cardiovasc Interv
; 96(4): E416-E422, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32134178
16.
In-hospital gastrointestinal bleeding following percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 95(1): 109-117, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30963681
17.
Impact of established cardiovascular disease on outcomes in the randomized global leaders trial.
Catheter Cardiovasc Interv
; 96(7): 1369-1378, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31854112
18.
Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial.
JAMA
; 324(3): 249-258, 2020 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-32692386
19.
Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1â¯month of dual antiplatelet therapy.
Am Heart J
; 214: 134-141, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31203158
20.
Clinical outcomes in unselected patients treated with the PROMUS Element platinum-chromium, everolimus-eluting stent: Final five-year results from the PE PROVE Study.
Catheter Cardiovasc Interv
; 93(3): 398-403, 2019 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30341836